Literature DB >> 19861610

Influence of tropical climate conditions on the quality of antihypertensive drugs from Rwandan pharmacies.

Marc Twagirumukiza1, An Cosijns, Eveline Pringels, Jean Paul Remon, Chris Vervaet, Luc Van Bortel.   

Abstract

The objective of this study was to assess the quality of antihypertensive drugs and to investigate the influence of tropical storage conditions. Drug content and in vitro dissolution tests were performed on 10 test formulations (from Rwanda) and 6 reference formulations (from Belgium or France) after purchase and after 6-month storage under long-term (25 +/- 2 degrees C and 60 +/- 5% relative humidity [RH]) and accelerated (40 +/- 2 degrees C and 75 +/- 5% RH) testing conditions. Twenty percent of test formulations were of substandard content at the time of purchase. After 6 months at accelerated testing conditions, 7 of 10 test formulations were substandard in content and 8 were substandard for the combined criteria of drug content and dissolution, whereas no reference drug became substandard. This study shows that, apart from some drugs being already substandard from purchase, accelerated testing conditions (simulating tropical climate) have deleterious effects on the majority of antihypertensive drug formulations found in the Rwandan market.

Mesh:

Substances:

Year:  2009        PMID: 19861610     DOI: 10.4269/ajtmh.2009.09-0109

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  The current availability of antiepileptic drugs in Zambia: implications for the ILAE/WHO "out of the shadows" campaign.

Authors:  Elwyn Nachanya Chomba; Alan Haworth; Edward Mbewe; Masharip Atadzhanov; Philimon Ndubani; Henry Kansembe; Gretchen Lano Birbeck
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

2.  Elixirs of death. International organizations are working towards a global solution to address the problem of falsified and substandard medicines, but progress has stagnated.

Authors:  Katrin Weigmann
Journal:  EMBO Rep       Date:  2013-06-14       Impact factor: 8.807

3.  Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries.

Authors:  Catherine E Vialle-Valentin; Brian Serumaga; Anita K Wagner; Dennis Ross-Degnan
Journal:  Health Policy Plan       Date:  2014-09-24       Impact factor: 3.344

Review 4.  Noncommunicable Diseases In East Africa: Assessing The Gaps In Care And Identifying Opportunities For Improvement.

Authors:  Trishul Siddharthan; Kaushik Ramaiya; Gerald Yonga; Gerald N Mutungi; Tracy L Rabin; Justin M List; Sandeep P Kishore; Jeremy I Schwartz
Journal:  Health Aff (Millwood)       Date:  2015-09       Impact factor: 6.301

Review 5.  Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries.

Authors:  Veronika J Wirtz; Warren A Kaplan; Gene F Kwan; Richard O Laing
Journal:  Circulation       Date:  2016-05-24       Impact factor: 29.690

Review 6.  Hypertension in Developing Countries: A Major Challenge for the Future.

Authors:  M Mohsen Ibrahim
Journal:  Curr Hypertens Rep       Date:  2018-05-01       Impact factor: 5.369

7.  Access to diagnostic tests and essential medicines for cardiovascular diseases and diabetes care: cost, availability and affordability in the West Region of Cameroon.

Authors:  Ahmadou M Jingi; Jean Jacques N Noubiap; Arnold Ewane Onana; Jobert Richie N Nansseu; Binhuan Wang; Samuel Kingue; André Pascal Kengne
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

8.  Quality of medicines in southern Togo: Investigation of antibiotics and of medicines for non-communicable diseases from pharmacies and informal vendors.

Authors:  Simon Schäfermann; Emmanuel Wemakor; Cathrin Hauk; Lutz Heide
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

9.  Noncommunicable diseases, access to essential medicines and universal health coverage.

Authors:  David Beran; Hanne Bak Pedersen; Jane Robertson
Journal:  Glob Health Action       Date:  2019       Impact factor: 2.640

Review 10.  Substandard drugs: a potential crisis for public health.

Authors:  Atholl Johnston; David W Holt
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.